Stefan Buguslawski, president of PEX Pharmasequence, a leading Polish healthcare consultancy and market research company, highlights the current obstacles facing the Polish healthcare market and the dynamics of the domestic pharmaceutical industry. He also discusses the innovative services they provide and how their offering will develop in the future.
As the president, could you introduce to our international readers PEX Pharmasequence?
"We are absolutely concentrated in the private sector as the public sector in Poland does not historically partner with consultancy firms."
